tradingkey.logo

Stereotaxis Inc

STXS
2.120USD
+0.090+4.43%
收盘 02/09, 16:00美东报价延迟15分钟
13.09M总市值
亏损市盈率 TTM

Stereotaxis Inc

2.120
+0.090+4.43%

关于 Stereotaxis Inc 公司

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

Stereotaxis Inc简介

公司代码STXS
公司名称Stereotaxis Inc
上市日期Aug 12, 2004
CEOFischel (David Leo)
员工数量139
证券类型Ordinary Share
年结日Aug 12
公司地址710 N Tucker Blvd
城市ST. LOUIS
上市交易所NASDAQ OMX – NASDAQ Basic Amex
国家United States of America
邮编63101
电话13146786100
网址https://www.stereotaxis.com/
公司代码STXS
上市日期Aug 12, 2004
CEOFischel (David Leo)

Stereotaxis Inc公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
13.97M
+46948.00%
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
553.92K
+46948.00%
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
392.06K
+46948.00%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
200.00K
+60000.00%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
185.59K
+46948.00%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+46948.00%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kimberly R. Peery
Ms. Kimberly R. Peery
Chief Financial Officer
Chief Financial Officer
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
13.97M
+46948.00%
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
553.92K
+46948.00%
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
392.06K
+46948.00%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
200.00K
+60000.00%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
185.59K
+46948.00%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+46948.00%

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
International
13.49M
50.12%
United States
13.43M
49.88%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 12月5日 周五
更新时间: 12月5日 周五
持股股东
股东类型
持股股东
持股股东
占比
Fischel (Nathan)
14.96%
Dafna Capital Management, LLC
14.66%
Kiani (Joe E)
9.49%
Lagoda Investment Management, L.P.
5.04%
The Vanguard Group, Inc.
3.96%
其他
51.88%
持股股东
持股股东
占比
Fischel (Nathan)
14.96%
Dafna Capital Management, LLC
14.66%
Kiani (Joe E)
9.49%
Lagoda Investment Management, L.P.
5.04%
The Vanguard Group, Inc.
3.96%
其他
51.88%
股东类型
持股股东
占比
Individual Investor
28.86%
Hedge Fund
19.47%
Investment Advisor
17.46%
Investment Advisor/Hedge Fund
9.42%
Corporation
3.30%
Research Firm
0.62%
Bank and Trust
0.07%
Venture Capital
0.04%
Pension Fund
0.01%
其他
20.75%

机构持股

更新时间: 1月5日 周一
更新时间: 1月5日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
186
43.95M
47.09%
-1.61M
2025Q3
175
41.68M
45.77%
-4.01M
2025Q2
184
70.71M
77.86%
+13.38M
2025Q1
192
70.55M
82.04%
+9.72M
2024Q4
185
55.40M
64.94%
-4.27M
2024Q3
178
54.77M
64.71%
-4.91M
2024Q2
173
55.07M
66.24%
-4.36M
2024Q1
185
55.40M
67.15%
-4.49M
2023Q4
184
51.49M
64.77%
-9.27M
2023Q3
189
52.12M
65.60%
-9.17M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Fischel (Nathan)
13.92M
15.35%
+43.67K
+0.31%
Jul 01, 2025
Dafna Capital Management, LLC
13.68M
14.66%
--
--
Sep 30, 2025
Kiani (Joe E)
8.86M
9.49%
+427.40K
+5.07%
Mar 17, 2025
Lagoda Investment Management, L.P.
4.71M
5.04%
+19.50K
+0.42%
Sep 30, 2025
The Vanguard Group, Inc.
3.44M
3.69%
+138.48K
+4.19%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.68M
3.94%
+76.90K
+2.13%
Sep 30, 2025
2012 Revocable Trust of Andrew Redleaf
3.08M
3.3%
--
--
Mar 17, 2025
Arbiter Partners Capital Management, LLC
2.85M
3.06%
--
--
Sep 30, 2025
Isaac (Paul J)
2.06M
2.21%
+10.00K
+0.49%
Nov 17, 2025
Essex Investment Management Company, LLC
1.60M
1.71%
+53.36K
+3.45%
Sep 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0.03%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
iShares Russell 2000 Value ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
占比0.03%
Global X Russell 2000 ETF
占比0.01%
Proshares Ultra Russell 2000
占比0.01%
ProShares UltraPro Russell2000
占比0.01%
ProShares Hedge Replication ETF
占比0.01%
iShares Russell 2000 Growth ETF
占比0.01%
iShares Russell 2000 Value ETF
占比0%
iShares Russell 2000 ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI